Genomics company Illumina (NASDAQ:ILMN) will be reporting earnings this Thursday afternoon. Here’s what to expect.

Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via ...

The stock's fall snapped a five-day winning streak.

The company calls itself a ‘pioneer’ of ultra-low-power chip solutions that can be used for edge AI, or processing data on ...